Accordingly, the compromised brain effect of endogenous or peripherally administered insulin in obesity might stem primarily from attenuated insulin transport to the brain as a result of hyperinsulinaemia [43, 44], which can be overcome by directly targeting the brain with IN insulin [45]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.